Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2008
03/13/2008WO2008012532A3 : pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
03/13/2008WO2008008718A3 Cyclopentane derivatives as antiglaucoma agents
03/13/2008WO2007146376A3 Substituted 3-cyanopyridines as protein kinase inhibitors
03/13/2008WO2007123939A8 Novel arylamino n-heteraryls as mek inhibitors
03/13/2008WO2007112299A3 Enzymatic preparation of (s) amino acid from (r,s) amino acid or from keto acid
03/13/2008WO2007107311A3 Organic sulphinic acid derivatives
03/13/2008US20080064731 Remedy for chronic disease
03/13/2008US20080064730 Insecticide, nematocides and for arachnids
03/13/2008US20080064729 Phenethylamide derivatives with kinase inhibitory activity
03/13/2008US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors
03/13/2008US20080064717 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease; N-(3-chlorophenyl)-N'-(4'-{(R)-hydroxy[(1R,2R)-2-(hydroxymethyl)cyclopentyl]methyl}-1,1'-biphenyl-4-yl)urea
03/13/2008US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency
03/13/2008US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
03/13/2008US20080064662 Agonists having a biphenyl moiety in combination with an amide linkage at the core of the structure enhances selectivity for S1P1 receptor without causing hypotension or bradycardia; transplant rejection, autoimmune diseases; 2-Amino-N-[4-(biphenyl-4-yloxy)-phenyl]3-hydroxy-2-methyl-propionamide
03/13/2008US20080064661 Dihydroxyl compounds and compositions for cholesterol management and related uses
03/13/2008US20080061684 Metal Complex Compound and Organic Electroluminescent Element Using the Same
03/13/2008CA2662852A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
03/13/2008CA2662850A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity
03/13/2008CA2662728A1 Substituted bipyridine derivatives and their use
03/13/2008CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
03/13/2008CA2660757A1 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines
03/12/2008EP1897870A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient
03/12/2008EP1897541A2 Hypoglycemic agent
03/12/2008EP1896417A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/12/2008EP1896416A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
03/12/2008EP1896396A1 Anthranilic acid derivatives
03/12/2008EP1896394A1 Substituted enaminones as nicotinic acetylcholine receptor modulators
03/12/2008EP1896082A2 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
03/12/2008EP1706382B1 Method for stabilizing 4-halogenpyridines with secondary and/or tertiary amines
03/12/2008EP1656405B1 Novel catalysts for selective isocyanate dimerisation
03/12/2008EP1613596B1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor
03/12/2008EP1539693B1 Cannabinoid receptor agonists
03/12/2008CN101142326A Methods of using dyes in association with nucleic acid staining or detection and associated technology
03/12/2008CN101142285A Reactive azo dyes, methods for the production thereof and their use
03/12/2008CN101142212A 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
03/12/2008CN101142190A Nicotinanilides method for production thereof and agents comprising the same for prevention of fungal pests
03/12/2008CN101142189A 2-pyridine derivatives as inhibitors of neutrophile elastase
03/12/2008CN101142188A 2-pyridine derivatives as inhibitors of neutrophile elastase
03/12/2008CN101142187A 离子型有机化合物 Ionic organic compounds
03/12/2008CN101142172A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
03/12/2008CN101141878A Biphenyl-n-(4-pyridyl)methylsulfonamides
03/12/2008CN101139318A Method for producing low-residual novel weedicide clopyralid
03/12/2008CN101139267A White black falsehellebore alcohol derivative, analogue and preparation method and use thereof
03/12/2008CN100374516C Printing process using specified azo compounds
03/12/2008CN100374448C Diene silicoxyane linking disbenzocyclobutylene monomer and process for preparing prepolymer
03/12/2008CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers
03/12/2008CN100374416C P-(sulfonyl)-aryl and heteroaryls amines
03/11/2008US7342131 Levodopa prodrugs, and compositions and uses thereof
03/11/2008US7342127 Substituted anilide ligands for the thyroid receptor
03/11/2008US7342116 Process for producing heterocyclic aldehyde
03/11/2008US7342115 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
03/11/2008US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis
03/11/2008US7342013 Benzamides and related inhibitors of factor Xa
03/11/2008US7341607 Yellow anionic disazo dyes
03/11/2008CA2310664C Substituted 2-aminoacetamides and the use thereof
03/11/2008CA2274954C Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
03/11/2008CA2192764C Integrin receptor antagonists
03/06/2008WO2008027073A1 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines
03/06/2008WO2008026577A1 Method for producing phenoxypyridine derivative
03/06/2008WO2008026563A1 Hydrazine amide derivative
03/06/2008WO2008025820A1 Aminopyridine derivates as kinase inhibitors
03/06/2008WO2008025694A1 Inhibitors for glyt-1
03/06/2008WO2008009360A3 N'-cyano-n-alkyl halide imide amide derivatives
03/06/2008WO2007149829A3 Therapeutic compounds
03/06/2008WO2007145835A3 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity
03/06/2008WO2007131201A3 Compounds and compositions as hedgehog pathway modulators
03/06/2008WO2007126733A3 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
03/06/2008US20080058546 Methods for Synthesis of Acyloxyalkyl Derivatives of GABA Analogs
03/06/2008US20080058543 Process for making chiral 1,4-disubstituted piperazines
03/06/2008US20080058528 Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile
03/06/2008US20080058522 Process For The Preparation Of Enantiomerically Enriched Beta Amino Acid Derivatives
03/06/2008US20080058521 Processes for the preparation of compounds
03/06/2008US20080058391 Novel compounds
03/06/2008US20080058383 Such as 2-methyl-2-(4-nitro-3-trifluoromethyl-phenylamino)-propan-1-ol; prostate cancer; cardiovascular disorders; psychological disorders
03/06/2008US20080058382 Polyamine compounds
03/06/2008US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example
03/06/2008US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis
03/06/2008US20080058331 Inhibitors for GlyT-1
03/06/2008US20080058323 Therapy of vascular system diseases
03/06/2008US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties
03/06/2008US20080058290 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders
03/06/2008US20080054223 Light Emitting Complex Salts
03/06/2008CA2661863A1 Inhibitors for glyt-1
03/06/2008CA2661702A1 Method for producing phenoxypyridine derivative
03/06/2008CA2661480A1 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines
03/05/2008EP1894917A1 Aryloxy- and arylthioxyacetophenone-type compounds for the treatment of cancer
03/05/2008EP1893609A1 N-(pyridin-2-yl)-sulfonamide derivatives
03/05/2008EP1893601A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives
03/05/2008EP1893597A2 Ampa receptor potentiators
03/05/2008EP1893579A1 1-hydroxycycloalkanecarboxamide derivatives as bradykinin antagonists
03/05/2008EP1893567A1 Benzanilides with insecticidal activity
03/05/2008EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
03/05/2008EP1893562A1 Reversible inhibitors of monoamine oxidase a and b
03/05/2008EP1893245A2 Radiolabeled-pegylation of ligands for use as imaging agents
03/05/2008EP1732541A4 Cyclic compounds
03/05/2008EP1641800B1 Pyrazolopyrimidines
03/05/2008EP1045836B1 Pyridones as src family sh2 domain inhibitors
03/05/2008CN101137643A Novel pyridine compounds
03/05/2008CN101137624A Compounds for inflammation and immune-related uses
03/05/2008CN101137616A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme